TuHURA Biosciences logo
TuHURA Biosciences
HURA | NASDAQ
Chart Builder DCF Calculator
$1.33
-$0.06 (-4.32%)
At close: Nov 16, 2026, 4:00 PM ET
$1.37
+$0.04 (+3.01%)
After-hours: Nov 16, 2026, 7:59 PM ET

TuHURA Biosciences Company Profile

Company profile explained

Company Profile

TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.

Key Executives

Name Position
James A. Bianco President, Chief Executive Officer & Director
Dan Dearborn Executive Vice President of Finance & Chief Financial Officer
Amanda Garofalo Senior Vice President of Clinical Operations
Michael Krsulich Head of Quality Assurance
Michael Lawman Co-Founder
Patricia Lawman Co-Founder

Latest SEC Filings

Date Type Title
Oct 16, 2026 8-K Current Report
Sep 24, 2026 8-K Current Report
Sep 17, 2026 8-K Current Report
Sep 17, 2026 8-K/A [Amend] Current Report
Sep 16, 2026 8-K Current Report
Sep 04, 2026 8-K Current Report
Aug 28, 2026 SC 13D/A [Amend] Filing
Aug 21, 2026 8-K Current Report
Aug 19, 2026 8-K Current Report
Aug 14, 2026 10-Q Quarterly Report
View All SEC Filings ➞
TuHURA Biosciences
TuHURA Biosciences logo
Country United States
IPO Date Feb 22, 2013
Industry Biotechnology
Sector Healthcare
Employees 22
CEO James A. Bianco

Contact Details

10500 University Center Drive Tampa, Florida 33612 United States

Stock Details

Ticker Symbol HURA
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001498382
CUSIP Number 898920103
ISIN Number US8989201038
SIC Code 2834

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.